The global uterine manipulation devices market accounted for USD 286.1 million in 2023 and is expected to reach at USD 539.1 million by 2034 with a CAGR of 5.93% during the forecast period 2024-2034. Rising incidence of diseases associated with female reproductive organs, increasing uptake of minimally invasive or non-invasive treatments, growing advancements in technology, surge in research & development efforts, uptick in the introduction of new products, rise in mergers & acquisitions within the market, and increase in the development of advanced uterine manipulation devices are some of the key factors boosting the market growth.
Increase in the development of advanced uterine manipulation devices is predicted to boost the market growth during the forecast period. Uterine manipulator devices are surgical tools utilized in gynecological procedures to securely stabilize the cervix while surgeons perform laparoscopic surgery within the female uterus. These devices are employed in a range of surgical procedures including total laparoscopic hysterectomy, posterior and anterior abdominal colpotomy, partial laparoscopic hysterectomy, laparoscopy-assisted hysterectomy, and laparoscopy-assisted vaginal hysterectomy. For instance, in June 2023, An atraumatic uterine manipulator for minimally invasive gynecological procedures has been developed by researchers from the Universitat Jaume I Biomechanics and Ergonomics research group in collaboration with the Fisabio Foundation, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) at the General University Hospital of Castelló, and others. This device aims to prevent injury to the initial tumor, minimize damage during uterine manipulation, and reduce the risk of potential carcinogen migration.
By application, total laparoscopy hysterectomy (TLH) was the highest revenue-grossing segment in the global uterine manipulation devices market in 2023 owing to the increasing incidence of uterine cancer, rise in the prevalence of conditions such as fibroids, pelvic pain, heavy menstrual periods, pre-cancerous or cancerous uterine conditions, endometriosis or adenomyosis, & prolapse, and growing preference for laparoscopic surgical procedures. Additionally, laparoscopic supracervical hysterectomy (LSH) is predicted to grow at the fastest CAGR during the forecast period owing to increasing dmeand for minimally invasive procedures, rising incidence of uterine conditions including fibroids, endometriosis, pelvic pain, aMnormal vaginal bleeding, and infections in the ovaries and fallopian tubes, and growing introduction of advanced laparoscopic devices. For instance, in January 2022, The National Medical Products Administration (NMPA) has approved the Toumai Laparoscopic Surgical Robot for commercialization, according to Shanghai MicroPort MedBot (Group) Co., Ltd. This marks the first instance of a Chinese company developing and gaining approval for a four-arm laparoscopic robot.
By end-user, hospitals was the highest revenue-grossing segment in the global uterine manipulation devices market in 2023 owing to the rise in the prevalence of gynecological conditions among patients, increase in surgical procedures, growing reimbursements for specific procedures, hospitals are increasingly utilizing technologically advanced devices to enhance treatment outcomes, and growing launch of advanced medical devices. For instance, in August 2023, The most sophisticated magnetic surgical platform from Levita Magnetics is now available for use by surgeons thanks to approval from the US Food and Drug Administration. Levita's Magnetic Surgery platform has been replaced with the MARS platform. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the growing inclination towards outpatient surgeries, rise in the adoption of minimally invasive procedures due to their cost-effectiveness. Laparoscopic procedures performed at ambulatory surgery centers are associated with shorter procedure times and same-day discharge compared to hospitals.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing incidence of gynecology-related surgical procedures & hospital visits, surge in robust healthcare infrastructure, favorable reimbursement policies, and increasing emphasis on the advancement of uterine manipulator devices. For instance, in January 2022, The study "Ultrasound Imaging of Acquired Myometrial Pseudoaneurysm: The Role of Manipulators as an Unusual Cause during Laparoscopic Surgery" produced positive results on the safety of using the ClearView Uterine Manipulator, 7 cm tip, in gynecological surgery. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the escalating demand for affordable & technologically advanced healthcare solutions, rise in clinical trial participation, increased research & development funding from key industry players, higher rates of hospital admissions, and an uptick in the introduction of cutting-edge systems. For instance, in November 2022, India Medtronic Private Limited unveiled the TruClear system, a mechanical hysteroscopic tissue removal system utilized for the safe and efficient management of intrauterine aMnormalities (IUA).
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increase in the development of advanced uterine manipulation devices is predicted to boost the market growth during the forecast period. Uterine manipulator devices are surgical tools utilized in gynecological procedures to securely stabilize the cervix while surgeons perform laparoscopic surgery within the female uterus. These devices are employed in a range of surgical procedures including total laparoscopic hysterectomy, posterior and anterior abdominal colpotomy, partial laparoscopic hysterectomy, laparoscopy-assisted hysterectomy, and laparoscopy-assisted vaginal hysterectomy. For instance, in June 2023, An atraumatic uterine manipulator for minimally invasive gynecological procedures has been developed by researchers from the Universitat Jaume I Biomechanics and Ergonomics research group in collaboration with the Fisabio Foundation, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) at the General University Hospital of Castelló, and others. This device aims to prevent injury to the initial tumor, minimize damage during uterine manipulation, and reduce the risk of potential carcinogen migration.
By application, total laparoscopy hysterectomy (TLH) was the highest revenue-grossing segment in the global uterine manipulation devices market in 2023 owing to the increasing incidence of uterine cancer, rise in the prevalence of conditions such as fibroids, pelvic pain, heavy menstrual periods, pre-cancerous or cancerous uterine conditions, endometriosis or adenomyosis, & prolapse, and growing preference for laparoscopic surgical procedures. Additionally, laparoscopic supracervical hysterectomy (LSH) is predicted to grow at the fastest CAGR during the forecast period owing to increasing dmeand for minimally invasive procedures, rising incidence of uterine conditions including fibroids, endometriosis, pelvic pain, aMnormal vaginal bleeding, and infections in the ovaries and fallopian tubes, and growing introduction of advanced laparoscopic devices. For instance, in January 2022, The National Medical Products Administration (NMPA) has approved the Toumai Laparoscopic Surgical Robot for commercialization, according to Shanghai MicroPort MedBot (Group) Co., Ltd. This marks the first instance of a Chinese company developing and gaining approval for a four-arm laparoscopic robot.
By end-user, hospitals was the highest revenue-grossing segment in the global uterine manipulation devices market in 2023 owing to the rise in the prevalence of gynecological conditions among patients, increase in surgical procedures, growing reimbursements for specific procedures, hospitals are increasingly utilizing technologically advanced devices to enhance treatment outcomes, and growing launch of advanced medical devices. For instance, in August 2023, The most sophisticated magnetic surgical platform from Levita Magnetics is now available for use by surgeons thanks to approval from the US Food and Drug Administration. Levita's Magnetic Surgery platform has been replaced with the MARS platform. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the growing inclination towards outpatient surgeries, rise in the adoption of minimally invasive procedures due to their cost-effectiveness. Laparoscopic procedures performed at ambulatory surgery centers are associated with shorter procedure times and same-day discharge compared to hospitals.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing incidence of gynecology-related surgical procedures & hospital visits, surge in robust healthcare infrastructure, favorable reimbursement policies, and increasing emphasis on the advancement of uterine manipulator devices. For instance, in January 2022, The study "Ultrasound Imaging of Acquired Myometrial Pseudoaneurysm: The Role of Manipulators as an Unusual Cause during Laparoscopic Surgery" produced positive results on the safety of using the ClearView Uterine Manipulator, 7 cm tip, in gynecological surgery. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the escalating demand for affordable & technologically advanced healthcare solutions, rise in clinical trial participation, increased research & development funding from key industry players, higher rates of hospital admissions, and an uptick in the introduction of cutting-edge systems. For instance, in November 2022, India Medtronic Private Limited unveiled the TruClear system, a mechanical hysteroscopic tissue removal system utilized for the safe and efficient management of intrauterine aMnormalities (IUA).
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Application and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Uterine Manipulation Devices Market Report 2023 - 203
Uterine Manipulation Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Sacrocolpopexy
- Laparoscopic Supracervical Hysterectomy (LSH)
- Total Laparoscopy Hysterectomy (TLH)
- Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
- Others
Uterine Manipulation Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Clinics
Uterine Manipulation Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Uterine Manipulation Devices Market: Application Estimates & Trend Analysis
8. Uterine Manipulation Devices Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Uterine Manipulation Devices Market
11. Europe Global Uterine Manipulation Devices Market
12. Asia Pacific Global Uterine Manipulation Devices Market
13. Latin America Global Uterine Manipulation Devices Market
14. MEA Global Uterine Manipulation Devices Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Johnson and Johnson
- CooperSurgical Inc.
- CONMED Corporation
- KARL STORZ GmbH & Co. KG
- Conkin Surgical Instruments Ltd.
- Clinical Innovations LLC
- B. Braun Medical Ltd.
- Utah Medical Products Inc.
- RUDOLF Medical GmbH + Co. KG
- Purple Surgical
- LiNA Medical ApS
- LSI Solutions Inc.
- Richard Wolf GmbH
- Bissinger Medizintechnik
- The O.R. Company (Symmetry Surgical Inc.)
